Amesite Inc. (AMST)

NCM – Цена в реальном времени. Валюта: USD

0.81

-0.01 (-0.80%)

При закрытии: May 12, 2026, 4:00 PM EDT

0.82

+0.01 (1.16%)

До открытия: May 13, 2026, 7:19 AM EDT

28.04.2026

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

$2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants $2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants

28.04.2026

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

DETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D, its Chairman and CEO, and George Parmer, a member of its board of directors, for the purchase and sale of an aggregate of 418,118 shares of its common stock, Series A-1 warrants to purchase an aggregate up to 418,118 shares of the Company's common stock and Series A-2 warrants to purchase an aggregate up to 418,118 shares of the Company's common stock at a purchase price of $1.435 per share and accompanying warrants. The private placement follows the Company's recently announced concurrent registered direct offering and private placement, priced at-the-market under Nasdaq rules, which is expected to result in aggregate gross proceeds to the Company of approximately $2 million, before deducting placement agent fees and other offering expenses.

27.04.2026

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the Company has agreed to issue to the investor unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock.

27.04.2026

Amesite Announces Withdrawal of Registration Statement on Form S-1

DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST) (the “Company”), a leading developer of AI-powered enterprise solutions, today announced that it has filed with the U.S. Securities and Exchange Commission (the “SEC”) a request for withdrawal of the Company's Registration Statement on Form S-1 (No. 333-295187) originally filed on April 20, 2026 (the “Registration Statement”), as the Company no longer intends to pursue a public offering under the Registration Statement at this time.

26.03.2026

Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform

Agreement Enables HIPAA-Compliant Exchange of EVV Transactions with Company Processing Billions of Dollars in Homecare Services Billed Annually Agreement Enables HIPAA-Compliant Exchange of EVV Transactions with Company Processing Billions of Dollars in Homecare Services Billed Annually

04.03.2026

Amesite's NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” Award

AMST's recognition from one of the largest online nursing communities follows step-change revenue growth as company targets a post-acute market expected to exceed $800 billion AMST's recognition from one of the largest online nursing communities follows step-change revenue growth as company targets a post-acute market expected to exceed $800 billion

19.12.2025

Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR

Company enters the infrastructure layer of post-acute care following sustained revenue expansion and enterprise adoption Company enters the infrastructure layer of post-acute care following sustained revenue expansion and enterprise adoption

Видео

No Data

There is no data to display

Пресс-релизы

28.04.2026

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

28.04.2026

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

27.04.2026

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

27.04.2026

Amesite Inc. (AMST)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Amesite Inc. (AMST)

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1

Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform

Amesite's NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” Award

Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR

Видео

No Data

Пресс-релизы

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1

Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform

Amesite's NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” Award

Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR

Видео

No Data

Пресс-релизы

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1

Search stocks

Amesite Inc. (AMST)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Amesite Inc. (AMST)

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1

Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform

Amesite's NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” Award

Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR

Видео

No Data

Пресс-релизы

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1

Amesite Executes Trading Partner Agreement Enabling Secure Connectivity with Leading Homecare Technology Platform

Amesite's NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” Award

Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR

Видео

No Data

Пресс-релизы

Amesite Announces Closing of Up To $7.8 Million Concurrent Registered Direct Offering and Private Placements Priced At-the-Market Under Nasdaq Rules

Amesite Announces Insider-Led Private Placement Priced at a Premium to Market

Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Amesite Announces Withdrawal of Registration Statement on Form S-1